The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabazitaxel versus enzalutamide/abiraterone in CARD eligible mCRPC patients with or without germline HRR defects.
 
Nuria Romero-Laorden
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen; Ipsen; Tesaro
Speakers' Bureau - Astellas Pharma; Janssen-Cilag; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Pfizer; Roche
 
Rebeca Lozano
Consulting or Advisory Role - Sanofi/Aventis
Speakers' Bureau - Janssen-Cilag; Roche
Research Funding - Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Roche
 
Casilda Llacer Perez
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Acraf; Astellas Pharma
 
Jose Maria M. Piulats Rodriguez
Consulting or Advisory Role - Astellas Pharma; BeiGene; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Janssen Oncology; Merck Sharp & Dohme; Pfizer/EMD Serono
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; Roche
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche
 
David Lorente
Consulting or Advisory Role - Bayer Health; Janssen Oncology; Sanofi/Aventis
Speakers' Bureau - Astellas Pharma; Bayer Health; Bristol-Myers Squibb; Janssen Oncology; Sanofi/Aventis
Travel, Accommodations, Expenses - Astellas Pharma; Celgene; Janssen Oncology; Pfizer; Sanofi/Aventis
 
Ana Medina
Honoraria - Bristol-Myers Squibb; Eisai; Eusa Pharma; Janssen-Cilag; Merck; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen-Cilag
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Janssen-Cilag; PharmaMar; Roche; Sanofi
Other Relationship - Novartis
 
Carlo Cattrini
No Relationships to Disclose
 
Francesca Vitrone
No Relationships to Disclose
 
Elena Almagro
Speakers' Bureau - MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Pablo Borrega
Honoraria - Bayer; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bayer; Pfizer; Sanofi
 
Nuria Lainez
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Pfizer; Roche; Sanofi
 
Leticia Rivera
No Relationships to Disclose
 
Rosa Villatoro
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Roche/Genentech; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen Oncology; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech; Sanofi
 
Amaia Hernandez
No Relationships to Disclose
 
Alejo Rodriguez-Vida
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; MSD; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; MSD; Pfizer; Roche
Research Funding - MSD; Pfizer; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; Novartis; Pfizer; Roche
 
Pedro P. López-Casas
No Relationships to Disclose
 
Enrique Gallardo Diaz
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca Spain; Bristol-Myers Squibb; Daiichi Sankyo; EUSA Pharma; Ipsen; Janssen Oncology; Merck KGaA; Pfizer; Roche; Sanofi; Shenzen Techdow Pharma
Speakers' Bureau - Astellas Pharma; Daiichi Sankyo; Eisai; Ipsen; LEO Pharma; Pfizer; Roche; Rovi
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Pfizer; Roche
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Janssen; Roche
 
David Olmos
Honoraria - Astellas Pharma (Inst); Bayer; Janssen
Consulting or Advisory Role - AstraZeneca (Inst); Bayer; Bayer (Inst); Clovis Oncology; Janssen; Janssen (Inst)
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen